LillyDirect: New Home Delivery Service for Eli Lilly’s Diabetes, Weight Loss and Migraine Drugs
XTalks
JANUARY 5, 2024
Eli Lilly launched LillyDirect this week, an online service that provides access to the company’s medicines, including its newly approved weight loss drug Zepbound (tirzepatide). Ricks, Lilly’s chair and CEO, in the company’s announcement. Zepbound was approved by the US Food and Drug Administration (FDA) in November 2023.
Let's personalize your content